Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL2909794

N.Nc1nc(CCCn2cc(-c3ccc(Cl)cc3Cl)c([N+](=O)[O-])c2)ccc1[N+](=O)[O-]

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.41
GSK3A P49840 3/20 0.41
CDK1 P06493 2/20 0.39
HSD11B1 P28845 1/20 0.39
CCNB2 O95067 1/20 0.38
CCNB1 P14635 1/20 0.38
CCNB3 Q8WWL7 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
APEX1 P27695 1/20 0.33
LMNA P02545 3/20 0.33
POLB P06746 1/20 0.33
NPBWR1 P48145 1/20 0.32
ALDH1A1 P00352 1/20 0.32
INPPL1 O15357 1/20 0.32
DPP4 P27487 2/20 0.31
DHFR P00374 1/20 0.31
PDE7A Q13946 1/20 0.31
IDO1 P14902 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL2912015 0.94 GSK3B (0.42) GSK3BGSK3ACDK1HSD11B1CCNB2
Ammonia Solution, Strong SCHEMBL2906802 0.93 GSK3B (0.41) GSK3BGSK3ACDK1HSD11B1CCNB2
Ammonia Solution, Strong SCHEMBL2912932 0.83 SMN1; SMN2 (0.47) GSK3BGSK3ATSHRLMNAALDH1A1
Ammonia Solution, Strong SCHEMBL2912310 0.78 HRH3 (0.41) GSK3BGSK3ADPP4
SCHEMBL6028956 0.75 GSK3B (0.38) GSK3BGSK3ACDK1HSD11B1CCNB2
Ammonia Solution, Strong SCHEMBL2908714 0.74 SMN1; SMN2 (0.42) GSK3BGSK3ALMNAALDH1A1DPP4
SCHEMBL1219415 0.73 GSK3B (0.51) GSK3BGSK3ACDK1HSD11B1CCNB2
SCHEMBL2910561 0.73 GSK3B (0.51) GSK3BGSK3ACDK1HSD11B1CCNB2
SCHEMBL2912175 0.72 GSK3B (0.51) GSK3BGSK3ACDK1HSD11B1CCNB2
SCHEMBL2911945 0.72 HSD11B1 (0.47) HSD11B1MAPK1LMNAPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed